Cargando…
Subgroups in the treatment of nasal polyposis with dupilumab: A retrospective study
Dupilumab has been shown to be safe and effective in treating chronic rhinosinusitis with polyposis (CRSwNP). There is to this date no published data whether subgroups like patients with aspirin exacerbated respiratory disease (AERD), increased histologic eosinophilia or elevated blood eosinophil or...
Autores principales: | Bertlich, Mattis, Freytag, Saskia, Dombrowski, Tobias, Jurmeister, Philipp, Spiegel, Jennifer Lee, Bertlich, Ines, Ihler, Friedrich, Weiss, Bernhard G., Haubner, Frank, Gröger, Moritz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666224/ https://www.ncbi.nlm.nih.gov/pubmed/36397403 http://dx.doi.org/10.1097/MD.0000000000031031 |
Ejemplares similares
-
Management of chronic rhinosinusitis with nasal polyps in Samter triad by low-dose ASA desensitization or dupilumab
por: Bertlich, Mattis, et al.
Publicado: (2021) -
Factors influencing outcomes in selective neck dissection in 661 patients with head and neck squamous cell carcinoma
por: Bertlich, Mattis, et al.
Publicado: (2022) -
Cancer stem cell markers in adenocarcinoma of the salivary glands - reliable prognostic markers?
por: Spiegel, Jennifer L., et al.
Publicado: (2020) -
Low Dose Betahistine in Combination With Selegiline Increases
Cochlear Blood Flow in Guinea Pigs
por: Kloos, Benedikt, et al.
Publicado: (2022) -
The course of subjective and objective chemosensory dysfunction in hospitalized patients with COVID-19: a 6-month follow-up
por: Bertlich, Mattis, et al.
Publicado: (2021)